GLOUCESTERSHIRE, UK, Nov 17, 2026 – Global engineering technologies company, Renishaw, has announced the release of LIBERTAS technology. This new software platform is designed to improve design freedom, productivity, and scalability in metal additive manufacturing (AM).
Developed for Renishaw’s RenAM 500 series systems, LIBERTAS technology is a production-focused software solution that offers greater control over laser parameters. Renishaw has harnessed this to release a support reduction package which reduces reliance on traditional support structures whilst improving unsupported (downskin) surface finish, helping manufacturers streamline workflows and lower the total cost per part.

In metal AM, support structures are necessary to manage thermal conditions and ensure build stability. However, they can increase material consumption, extend build times and require additional post-build finishing to remove support witnesses.
LIBERTAS technology addresses these challenges by dynamically changing how laser energy is applied across the geometry of the component, enabling more effective control of heat during the build process. This improved thermal management reduces the need for support structures and allows more extreme downskin angles, by maintaining build stability and minimising distortion.

Manufacturers can reduce material usage, shorten post-processing requirements and achieve improved surface quality, particularly on downskin features. The result is a more predictable and efficient end-to-end process, supporting both low-volume production and scaled manufacturing without the need for additional hardware or significant changes to existing workflows.
“LIBERTAS technology is an enabler, bringing metal AM’s benefits to a greater range of volume production applications,” said Benjamin Diaz, Principal Software Product Manager at Renishaw. “By reducing dependence on support structures, and improving unsupported surface finishes, we are unlocking geometries that were previously unviable due to traditional design for additive manufacturing (DFAM) constraints, we are helping customers improve throughput, reduce waste and decrease cost-per-part — all while using the systems they already have in place.”
As a software-based solution integrated within Renishaw’s QuantAM build preparation platform, LIBERTAS technology can be deployed without additional hardware investment. Its flexible licensing model, based on individual QuantAM seats, allows build files to be used across multiple machines, supporting cost-effective scaling of AM operations and a high degree of operational flexibility.

“LIBERTAS technology is designed to support manufacturers across a range of industries, from low-volume, high-value through to full-scale serial production,” added Diaz. “By improving efficiency across the entire AM process, from build preparation to post-processing, the technology helps users achieve more consistent results and greater operational control.”

Visit us at Formnext in Frankfurt, 17th to 19th November on Stand C11, Hall 11, to see LIBERTAS technology in action.
To learn more about LIBERTAS technology, visit www.renishaw.com/libertas or contact ampdnews@renishaw.com.
About Renishaw
Renishaw is a world leading supplier of measuring systems and manufacturing systems. Its products give high accuracy and precision, gathering data to provide customers and end users with traceability and confidence in what they’re making. This technology also helps its customers to innovate their products and processes.
It is a global business with over 5,000 employees located in the 36 countries where it has wholly owned subsidiary operations. The majority of R&D work takes place in the UK, with the largest manufacturing sites located in the UK, Ireland and India.
For the year ended June 2025 Renishaw recorded sales of £713 million of which 95% was due to exports. The company’s largest markets are China, USA, Japan and Germany.
Renishaw is guided by its purpose: Transforming Tomorrow Together. This means working with its customers to make the products, create the materials, and develop the therapies that are going to be needed for the future.
Further information at www.renishaw.com.




